Virtual Medicinal Product (VMP)
-
Loxapine 9.1mg/dose inhalation powder
Name Details
Current Name
Loxapine 9.1mg/dose inhalation powder
|
Start Date
11-05-2016
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- dose
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Inhalation powder
- Ontology Form/Route
- powderinhalation.inhalation
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N05AH01
SNOMED Codes
Code
|
Start Date
|
End Date
|
32687711000001109 |
11-05-2016 |
|
VMP Ingredients
VMP ingredients table
Loxapine |
Based on Ingredient Substance |
|
9.1 mg |
|
Name
Loxapine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
9.1
Strength and UOM (Dmr)
Parent Products
-
VTM
Loxapine
-
VMP
(Current) Loxapine 9.1mg/dose inhalation powder
Virtual Medicinal Product Pack (VMPP) Information